Brain Glioma Registry Combining Clinical and Imaging Information

Launched by ASAN MEDICAL CENTER · Dec 1, 2015

Keywords

ClinConnect Summary

This clinical trial, called the Brain Glioma Registry, is focused on collecting important information about patients with brain gliomas, a type of brain tumor. Researchers want to gather details about patients' medical histories, treatments they receive, and advanced imaging results, which are special types of MRI scans that help doctors see the brain tumors more clearly. The goal is to better understand how these tumors behave over time and to learn about the long-term outcomes for patients.

To participate in this study, you must have a confirmed diagnosis of brain glioma and be expected to live for at least three more months. You also need to be receiving your first or second treatment for the tumor and agree to take part by signing a consent form. Unfortunately, individuals with certain medical devices, such as pacemakers or cochlear implants, cannot join this study, nor can pregnant or breastfeeding women. If you are eligible and choose to participate, you will help contribute to valuable research that could improve the understanding and treatment of brain gliomas for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients must have radiologically and histologically confirmed diagnosis of Brain Glioma
• • Life expectancy of greater than 3 months
• • Must receive a first- or second-line therapy
• • Signed informed consent
• Exclusion Criteria:
• • No brain gliomas
• • Patients who have any type of bioimplant activated by mechanical, electronic, or magnetic means (e.g., cochlear implants, pacemakers, neurostimulators, biostimulates, electronic infusion pumps, etc), because such devices may be displaced or malfunction
• • Patients who are pregnant or breast feeding; urine pregnancy test will be performed on women of child bearing potential